Market research
002390.SHE Guizhou Xinbang Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6B
- P/E ratio
- 50.33
- Analyst target
- 7.37
- Dividend yield
- 2.9%
- Beta
- 0.12
Community
Investor discussion
1 comment
Sign in to join the 002390.SHE discussion.
5 years, 5 months ago
Guizhou Xinbang Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 4.6% above its 200 day moving average.
From a valuation standpoint, the stock is 74.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Guizhou Xinbang Pharmaceutical Co., Ltd's total revenue sank by 4.3% to $2B since the same quarter in the previous year.
Its net income has increased by 39.2% to $50M since the same quarter in the previous year.
Finally, its free cash flow fell by 16.3% to $180M since the same quarter in the previous year.
Based on the above factors, Guizhou Xinbang Pharmaceutical Co., Ltd gets an overall score of 3/5.